

















httpFrequency-domain optical coherence tomography
assessment of very late vascular response after
carotid stent implantation
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Intravascular optical coherence tomography is a high-resolution invasive imaging modality that allows the evaluation of
vascular responses after stent implantation in a micron-scale level. We describe for the ﬁrst time two patients with very late
vascular response after carotid artery stenting that exhibit two different patterns of low-signal intensity (LSI), “ill-
appearing” neointima: the ﬁrst patient shows layered LSI neointima leading to stent restenosis, coupled with the presence
of intraluminal thrombus, whereas the second patient demonstrates another pattern of non-restenotic LSI stent strut
coverage, suggestive of lipid laden neointima (ie, “neoatherosclerosis”), recently associated with stent failure in coronary
arteries. (J Vasc Surg 2013;58:201-4.)Carotid artery stenting (CAS) has emerged as an alter-
native to carotid endarterectomy for the treatment of
carotid artery disease. Our understanding of the mecha-
nisms underlying CAS failure, however, remains limited
because, as opposed to the coronary circulation, stent–
vessel interactions in carotid arteries have not been
extensively studied. The recent U.S. Food and Drug Ad-
ministration clinical approval of frequency-domain optical
coherence tomography (FD-OCT), a light-based intravas-
cular imaging modality that provides an unprecedentedly
detailed micron-level (10-mm axial resolution) evaluation
of vascular response to the stent, may open a new avenue
for assessment of plaque morphology and stent–vessel inter-
actions in the carotid arteries.1 We recently demonstrated
the feasibility of FD-OCT to image atherosclerosis and
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features of abnormal very late vascular response to CAS
that may be implicated in adverse clinical outcomes. Image
acquisition was performed by means of an automated pull-
back without proximal balloon occlusion. Blood clearance
was obtained with the injection of 20 mL pure contrast.
The studies reported here were done in the Baptist Heart
and Vascular Institute after patients signed informed
consent. The use of FD-OCT to facilitate clinical manage-
ment in the reported patients and retrospective review and
reporting of cases were approved by Baptist Hospital Insti-
tutional Review Board.CASE REPORTS
Patient 1. A 62-year-old woman underwent carotid endarter-
ectomy of the right internal carotid artery (RICA) in 2003, and
5 years later, she underwent CAS for the treatment of RICA
high-degree asymptomatic surgical restenosis. Carotid ultrasound
imaging in this asymptomatic patient 4 years later suggested severe in-
stent restenosis, documented by peak systolic velocity of 436 m/s,
peak diastolic velocity of 150 m/s, and internal carotid-to-common
carotid artery ratio of 6.7. Subsequent angiography, however,
demonstrated only a proximal 55% in-stent restenosis in the right
common carotid artery, without signs of plaque instability or
thrombus (Fig 1, A), whereas FD-OCT (C7-XRTM OCT Intra-
vascular Imaging System; St. Jude Medical, St. Paul, Minn) imag-
ing revealed different patterns of vascular reaction within the same
stent (Fig 1,B, cross-sections 1-6), as follows: normal pattern (ie, high
signal intensity) of neointimal hyperplasia, layered low signal intensity
(LSI) in-stent tissue with organized thrombus and signiﬁcant luminal
narrowing (minimal cross-section area, 5.1 mm2; area stenosis, 70%),
as well as intraluminal, nonorganized, thrombus.201
Fig 1. Layered low signal intensity (LSI) vascular response very late after carotid stent implantation. A, Angiogram
demonstrates in-stent (stent contour is highlighted by the blue dashed lines) restenosis in the right common carotid
artery (white arrow). B, The restenotic segment can be seen in the longitudinal view of frequency-domain optical
coherence tomography image. The numbered red dashed circles correspond to the numbered cross-sections (1-6). A
normal-appearing, high signal intensity stent strut coverage pattern is revealed in 1, whereas in 2 a LSI pattern of
coverage and organized thrombus (white arrow) are demonstrated. Similar LSI layered stent coverage pattern is
visualized in 3 with the presence of intraluminal thrombus (white arrow). In 4, LSI coverage coupled with organized
thrombus prevents adequate visualization of stent struts. The most restenotic cross-section, which exhibits a clearly
layered LSI tissue covering the stent struts, is depicted in 5. More proximally, although a normal stent coverage pattern
(ie, high signal intensity) can be visualized in part of the cross-section, LSI tissue is still present (white asterisk).
Fig 2. Image shows massive low signal intensity (LSI) tissue prolapse after carotid stenting for the treatment of in-stent
restenosis. A, Two layers of stent struts are visualized revealing minimal tissue prolapse. B and C, Marked tissue
prolapse of layered LSI stent strut coverage is demonstrated (white arrows).
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treated with CAS using a Xact Carotid Stent System (Abbott
Vascular, Santa Clara, Calif). FD-OCT pullback after stent implan-
tation demonstrated that despite using a closed-cell stent design,a large amount of LSI tissue prolapse occurred (Fig 2). The patient
remains asymptomatic.
Patient 2. A 76-year-old man underwent CAS in RICA for
symptomatic stenosis (Carotid Revascularization Endarterectomy
Fig 3. Image shows in-stent lipid-laden neointimal hyperplasia with inﬂammation and two sites of plaque rupture. A,
The carotid angiogram demonstrates a ﬁlling defect in the right internal carotid artery, suggestive of thrombus (black
arrow). B, Six weeks after antiplatelet and antithrombin therapy, the ﬁlling defect is almost completely resolved. C,
Frequency-domain optical coherence tomography assessment demonstrates a pattern of stent strut coverage that leads
to marked light attenuation without clear borders, suggestive of lipid-laden neointima (white asterisks), which prevents
adequate visualization of stent struts (white arrowheads). D, The longitudinal view of frequency-domain optical
coherence tomography shows a site of plaque rupture (white arrow). E, Two different sites of intrastent plaque rupture
without overlying thrombus (white arrows) and diffuse lipid-laden neointima (white asterisks) are depicted. F, The
bright spots visualized in a ruptured ﬁbrous cap (red arrows) might correspond to macrophage inﬁltration, while the
white arrowhead shows a stent strut embedded in lipid-laden neointima.
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with left-sided weakness, with multiple small right middle cere-
bral artery distribution infarcts demonstrated by magnetic reso-
nance imaging (not shown). Carotid angiography demonstrated an
intraluminal ﬁlling defect (Fig 3, A) suggesting the presence of
thrombus within the stent.
After a 6-week course of antiplatelet and antithrombin
therapy, the patient returned for further studies to assess residual
thrombus and underlying plaque morphology to help clarify the
mechanisms of stent failure. Although angiography demonstrated
almost complete resolution of the angiographic “haziness”(Fig 3, B), FD-OCT revealed intrastent plaque rupture, without
overlying thrombus, and a nonobstructive uniform LSI tissue
with signs of macrophage inﬁltrate,3 diffuse borders, and high
attenuation of light that limited adequate stent strut visualization
(Fig 3, C-F). The patient has remained asymptomatic on medical
therapy with clopidogrel and a statin.
DISCUSSION
The present report provides the ﬁrst evidence of “ill-
appearing” in-stent tissue observed by FD-OCT very late
(4 and 8 years) after implantation of bare-metal stents in
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wall response observed in these two patients resembles
the optical features of pathologic neointimal tissue after
drug-eluting stent (DES) implantation in the coronary
circulation.
Patient 1 showed layered LSI tissue suggestive of hypo-
cellular matrix with abundant proteoglycan, similar to what
we have described as a “black hole” in the coronary circu-
lation.4 Despite the patient’s asymptomatic status, the pres-
ence of organized and intraluminal white thrombus is
alarming because it suggests a “high-risk,” prothrombotic
vascular milieu.5
The second patient had homogeneous LSI in-stent
tissue suggestive of lipid-laden neointima, with signs of
inﬂammation, and two sites of rupture. There was no
FD-OCT evidence of overlying thrombus, likely because
of anticoagulation therapy. Although a cause-and-effect
relationship cannot be extrapolated, similar OCT ﬁndings
have been recently suggested as a possible underlying
mechanism of stent thrombosis and acute coronary
syndromes late after coronary stent implantation.6
The potent antiproliferative cellular effects of DES, and
inﬂammatory reaction to polymers or hypersensitivity to
both have been blamed for similarly abnormal OCT ﬁnd-
ings in the coronary circulation.7 Although late abnormal
neointimal proliferation has long been observed in coro-
nary arteries treated with radiotherapy and DES, only
recently has the term “neoatherosclerosis” been used to
describe such vascular responses.6 The present patients
revealed that these are neither exclusive to the coronary
artery nor to DES.
Although FD-OCT is currently the best image
modality to investigate vascular response to stents, it is
important to recognize the limitations of the method
because different materials may have similar optical proper-
ties. For example, proteoglycan-rich tissue, ﬁbrin accumu-
lation surrounding stents, excessive inﬂammation, and
stent neoatherosclerosis may appear as LSI tissue in an
FD-OCT assessment.8 Nevertheless, one can rely on
optical properties coupled with additional morphologic
characteristics (ie, layered vs nonlayered, regular vsirregular, well deﬁned vs poorly deﬁned borders) to differ-
entiate normal from abnormal tissue in vivo based on
previous histopathologic validation.7 To date, examination
of intrastent tissue in the carotid vasculature has been
largely by angiographic analysis that yields only gross
quantitative data.
These seminal FD-OCT ﬁndings of late “high-risk” arte-
rial reactions to CAS unravel a potentially important, yet
unrecognized, mechanism of CAS failures that may have
clinical relevance in a vascular tree where, unlike the coro-
nary tree, symptoms are largely due to embolic events rather
than to obstructive disease. Future prospective, large-scale
studies are warranted to determine the frequency and treat-
ment of very late pathologic arterial reaction after CAS.
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